In vitro evaluation of the antimicrobial efficacy of a new silver-triclosan vs a silver collagen-coated polyester vascular graft against methicillin-resistant Staphylococcus aureus

Journal of Vascular Surgery

Volumn 55, Issue 3, 2012, Pages 823-829

  Ricco, Jean Baptiste ^a   Assadian, Afshin ^b   Schneider, Fabrice ^a   Assadian, Ojan ^c  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b WILHELMINEN HOSPITAL   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETATE SILVER; ANTIBIOTIC AGENT; COLLAGEN; POLYESTER; SILVER; SILVER ACETATE PLUS TRICLOSAN; TRICLOSAN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BLOOD VESSEL GRAFT; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; GRAFT INFECTION; IN VITRO STUDY; MATERIAL COATING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PLATE COUNT; PRIORITY JOURNAL;

ACETATES; ANTI-INFECTIVE AGENTS, LOCAL; BLOOD VESSEL PROSTHESIS; COATED MATERIALS, BIOCOMPATIBLE; COLLAGEN; COLONY COUNT, MICROBIAL; DRUG CARRIERS; DRUG COMBINATIONS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL VIABILITY; POLYESTERS; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; SILVER COMPOUNDS; TIME FACTORS; TRICLOSAN;

EID: 84857624986     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.08.015     Document Type: Article

References (46)

1. R.O. Darouiche Treatment of infections associated with surgical implants N Engl J Med 350 2004 1422 1429 (Pubitemid 38419996)
2. P.S. Barie Surgical site infections: epidemiology and prevention Surg Infect (Larchmt) 3 Suppl 1 2002 S9 S21
3. S.E. Wilson New alternatives in management of the infected vascular prosthesis Surg Infect (Larchmt) 2 2001 171 177
4. J.M. Seeger Management of patients with prosthetic vascular graft infection Am Surg 66 2000 166 177 (Pubitemid 30106301)
5. D. Zeltsman, C.D. Tzarnas, M.D. Kerstein Management of vascular prosthetic infections: results of long-term follow-up Am Surg 65 1999 331 333 (Pubitemid 29155954)
6. G. DeRose, J.L. Provan Infected arterial grafts: clinical manifestations and surgical management J Cardiovasc Surg 25 1984 51 57 (Pubitemid 14142037)
7. A. Kudva, R.J. Hye Management of infectious and cutaneous complications in vascular access Semin Vasc Surg 10 1997 184 190 (Pubitemid 27392411)
8. F.T. Padberg Jr, K.D. Calligaro, A.N. Sidawy Complications of arteriovenous hemodialysis access: recognition and management J Vasc Surg 48 2008 55S 80S
9. H.J. Gassel, I. Klein, U. Steger, R. Kellersmann, W. Hamelmann, S. Franke Surgical management of prosthetic vascular graft infection: comparative retrospective analysis of 30 consecutive cases VASA 31 2002 48 55 (Pubitemid 34208463)
10. J.S. Coselli, C. Kksoy, S.A. LeMaire Management of thoracic aortic graft infections Ann Thorac Surg 67 1999 1990 1993 (Pubitemid 29301398)
11. L. Reilly Aortic graft infection: evolution on management Cardiovasc Surg 10 2002 372 377 (Pubitemid 35299937)
12. B.R. Saleem, R. Meerwaldt, I.F. Tielliu, E.L. Verhoeven, J.J. van den Dungen, C.J. Zeebregts Conservative treatment of vascular prosthetic graft infection is associated with high mortality Am J Surg 200 2010 47 52
13. D.F. Bandyk, M.L. Novotney, M.R. Back, B.L. Johnson, D.C. Schmacht Expanded application of in situ replacement for prosthetic graft infection J Vasc Surg 34 2001 411 419
14. A.N. Sidawy, L.M. Spergel, A. Besarab, M. Allon, W.C. Jennings, F.T. Padberg Jr The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access J Vasc Surg 48 Suppl 1 2008 2S 25S
15. C. Setacci, G. De Donato, F. Setacci, E. Chisci, A. Perulli, G. Galzerano Management of abdominal endograft infection J Cardiovasc Surg [Torino] 51 2010 33 41
16. A.T. Ali, J.G. Modrall, J. Hocking, R.J. Valentine, H. Spencer, J.F. Eidt Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts J Vasc Surg 50 2009 30 39
17. A.B. Kaiser, K.R. Clayson, J.L. Mulherin Jr, A.C. Roach, T.R. Allen, W.H. Edwards Antibiotic prophylaxis in vascular Surgery Ann Surg 188 1978 283 289 (Pubitemid 9018172)
18. C.J.L. Strachan Antibiotic prophylaxis in peripheral vascular and orthopaedic prosthetic surgery J Antimicrob Chemother 31 Suppl B 1993 65 78 (Pubitemid 23099282)
19. M. Marroni, P. Cao, M. Fiorio, M. Maghini, M. Lenti, A. Repetto Prospective, randomized, double-blind trial comparing teicoplanin and cefazolin as antibiotic prophylaxis in prosthetic vascular surgery Eur J Clin Microbiol Infect Dis 18 1999 175 178 (Pubitemid 29527950)
20. S. Patrick, C. James, A. Ali, S. Lawson, E. Mary, A. Modak Vascular surgical antibiotic prophylaxis study (VSAPS) Vasc Endovasc Surg 44 2010 521 528
21. N. Blanchemain, T. Laurent, F. Chai, C. Neut, S. Haulon, V. Krump-konvalinkova Polyester vascular prostheses coated with a cyclodextrin polymer and activated with antibiotics: cytotoxicity and microbiological evaluation Acta Biomater 4 2008 1725 1733
22. T.J. Bunt Vascular graft infections: an update Cardiovasc Surg 9 2001 225 233 (Pubitemid 32381070)
23. T. Ueberrueck, L. Meyer, R. Zippel, G. Nestler, T. Wahlers, I. Gastinger Healing characteristics of a new silver-coated, gelatine impregnated vascular prosthesis in the porcine model Zentralbl Chir 130 2005 71 77
24. J.B. Ricco InterGard Silver Study Group for the InterGard Silver Study Group InterGard silver bifurcated graft: features and results of a multicenter clinical study J Vasc Surg 44 2006 339 346
25. S. Schaefler, W. Perry, D. Jones Methicillin-resistant strains of Staphylococcus aureus phage type 92 Antimicrob Agents Chemother 15 1979 74 80 (Pubitemid 9099635)
26. R.A. Yeager, J.M. Porter Arterial and prosthetic graft infection Ann Vasc Surg 6 1992 485 491 (Pubitemid 23017801)
27. A.R. Naylor, P.D. Hayes, S. Darke A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA Eur J Vasc Endovasc Surg 21 2001 289 294 (Pubitemid 32529993)
28. K. Daenens, I. Fourneau, A. Nevelsteen Ten-year experience in autogenous reconstruction with the femoral vein in the treatment of aortofemoral prosthetic infection Eur J Vasc Endovasc Surg 25 2003 240 245 (Pubitemid 36527618)
29. S. Hardman, A. Cope, A. Swann, P.R. Bell, A.R. Naylor, P.D. Hayes An in vitro model to compare the antimicrobial activity of silver-coated versus rifampicin-soaked vascular grafts Ann Vasc Surg 18 2004 308 313 (Pubitemid 38691563)
30. National Committee for Clinical Laboratory Standards Methods for determining bactericidal activity of antimicrobial agents; approved guideline NCCLS document M26-A 1999 National Committee for Clinical Laboratory Standards Wayne, PA 1-56238-384-1
31. C.L. Gallant-Behm, H.Q. Yin, S. Liu, J.P. Heggers, R.E. Langford, M.E. Olson Comparison of in vitro disc diffusion and time kill-kinetic assays for the evaluation of antimicrobial wound dressing efficacy Wound Repair Regen 13 2005 412 421 (Pubitemid 41060423)
32. P. Gilbert, A.J. McBain Literature-based evaluation of the potential risks associated with impregnation of medical devices and implants with triclosan Surg Infect [Larchmt] 3 Suppl 1 2002 S55 S63
33. G. McDonnell, A.D. Russell Antiseptics and disinfectants: activity, action, and resistance Clin Microbiol Rev 12 1999 147 179 (Pubitemid 29055958)
34. S. Rothenburger, D. Spangler, S. Bhende, D. Burkley In vitro antimicrobial evaluation of Coated Vicryl (*) plus antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays Surg Infect [Larchmt] 3 Suppl 1 2002 S79 S87
35. Scientific Committee on Consumer Products (SCCP) Opinion on triclosan Brussels: European Commission, Health & Consumer Protection DG http://ec.europa.eu/health/ph-risk/committees/04-sccp/docs/sccp-o-166.pdf Accessed May 24, 2011
36. A. Kramer, O. Assadian Praxis of sterilization, disinfection, and antisepsis 6th ed. 2008 Georg Thieme Verlag Stuttgart 760 768
37. C.M. Cooney Triclosan comes under scrutiny Environ Health Perspect 118 2010 a242
38. A.P. Lozier, R.R. Sciacca, M.F. Romagnoli, E.S. Connolly Jr Ventriculostomy-related infections: a critical review of the literature Neurosurgery 51 2002 170 181
39. N. Safdar, D.M. Kluger, D.G. Maki A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies Medicine (Baltimore) 81 2002 466 479 (Pubitemid 35285966)
40. D.P. Lew, D. Pittet, F.A. Waldvogel Infections that complicate the insertion of prosthetic devices G. Mayhall, Hospital epidemiology and infection control 3rd ed. 2004 Lippincott, Williams and Wilkins Philadelphia 1181 1205
41. B.M. Knoll, L.M. Baddour, W.R. Wilson Prosthetic valve endocarditis G.L. Mandell, J.E. Bennett, R. Dolin, Principles and practice of infectious diseases 7th ed. 2010 Churchill Livingston Oxford 1113 1126
42. J.M. Seeger Management of patients with prosthetic vascular graft infection Am Surg 66 2000 166 177 (Pubitemid 30106301)
43. G.S. Oderich, J.M. Panneton Aortic graft infections: what have we learnt during the last decades? Acta Chir Belg 102 2002 7 13
44. M.F. Sampedro, R. Patel Infections associated with long-term prosthetic devices Infect Dis Clin North Am 21 2007 785 819 (Pubitemid 47364821)
45. A.J. McBain, R.G. Bartolo, C.E. Catrenich, D. Charbonneau, R.G. Ledder, B.B. Price Exposure of sink drain microcosms to triclosan: population dynamics and antimicrobial susceptibility Appl Environ Microbiol 69 2003 5433 5442 (Pubitemid 37150768)
46. E. Zetrenne, B.C. McIntosh, M.H. McRae, R. Gusberg, G.R. Evans, D. Narayan Prosthetic vascular graft infection: a multi-center review of surgical management Yale J Biol Med 80 2007 113 121